P547: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKAEMIA TREATED WITH VENETOCLAX COMBINATION THERAPY: REAL-WORLD EXPERIENCE IN BOTH FRONTLINE AND RELAPSED/REFRACTORY SETTINGS
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-06-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000845076.68865.45 |
_version_ | 1827332491194662912 |
---|---|
author | H. P. J. Lam S. Leong Z. Kirkham A. Wilson R. Burt R. Sellar A. Fielding R. Gupta E. Payne M. Mansour P. Kottaridis A. Khwaja J. O’Nions |
author_facet | H. P. J. Lam S. Leong Z. Kirkham A. Wilson R. Burt R. Sellar A. Fielding R. Gupta E. Payne M. Mansour P. Kottaridis A. Khwaja J. O’Nions |
author_sort | H. P. J. Lam |
collection | DOAJ |
first_indexed | 2024-03-07T17:01:45Z |
format | Article |
id | doaj.art-33b5d59d329e4ef491ea42685c8ba2c0 |
institution | Directory Open Access Journal |
issn | 2572-9241 |
language | English |
last_indexed | 2024-03-07T17:01:45Z |
publishDate | 2022-06-01 |
publisher | Wiley |
record_format | Article |
series | HemaSphere |
spelling | doaj.art-33b5d59d329e4ef491ea42685c8ba2c02024-03-03T03:19:39ZengWileyHemaSphere2572-92412022-06-01644644710.1097/01.HS9.0000845076.68865.45202206003-00446P547: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKAEMIA TREATED WITH VENETOCLAX COMBINATION THERAPY: REAL-WORLD EXPERIENCE IN BOTH FRONTLINE AND RELAPSED/REFRACTORY SETTINGSH. P. J. Lam0S. Leong1Z. Kirkham2A. Wilson3R. Burt4R. Sellar5A. Fielding6R. Gupta7E. Payne8M. Mansour9P. Kottaridis10A. Khwaja11J. O’Nions121 Department of Haematology1 Department of Haematology1 Department of Haematology1 Department of Haematology1 Department of Haematology1 Department of Haematology1 Department of Haematology1 Department of Haematology1 Department of Haematology1 Department of Haematology1 Department of Haematology1 Department of Haematology1 Department of Haematologyhttp://journals.lww.com/10.1097/01.HS9.0000845076.68865.45 |
spellingShingle | H. P. J. Lam S. Leong Z. Kirkham A. Wilson R. Burt R. Sellar A. Fielding R. Gupta E. Payne M. Mansour P. Kottaridis A. Khwaja J. O’Nions P547: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKAEMIA TREATED WITH VENETOCLAX COMBINATION THERAPY: REAL-WORLD EXPERIENCE IN BOTH FRONTLINE AND RELAPSED/REFRACTORY SETTINGS HemaSphere |
title | P547: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKAEMIA TREATED WITH VENETOCLAX COMBINATION THERAPY: REAL-WORLD EXPERIENCE IN BOTH FRONTLINE AND RELAPSED/REFRACTORY SETTINGS |
title_full | P547: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKAEMIA TREATED WITH VENETOCLAX COMBINATION THERAPY: REAL-WORLD EXPERIENCE IN BOTH FRONTLINE AND RELAPSED/REFRACTORY SETTINGS |
title_fullStr | P547: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKAEMIA TREATED WITH VENETOCLAX COMBINATION THERAPY: REAL-WORLD EXPERIENCE IN BOTH FRONTLINE AND RELAPSED/REFRACTORY SETTINGS |
title_full_unstemmed | P547: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKAEMIA TREATED WITH VENETOCLAX COMBINATION THERAPY: REAL-WORLD EXPERIENCE IN BOTH FRONTLINE AND RELAPSED/REFRACTORY SETTINGS |
title_short | P547: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKAEMIA TREATED WITH VENETOCLAX COMBINATION THERAPY: REAL-WORLD EXPERIENCE IN BOTH FRONTLINE AND RELAPSED/REFRACTORY SETTINGS |
title_sort | p547 characteristics and outcomes of patients with acute myeloid leukaemia treated with venetoclax combination therapy real world experience in both frontline and relapsed refractory settings |
url | http://journals.lww.com/10.1097/01.HS9.0000845076.68865.45 |
work_keys_str_mv | AT hpjlam p547characteristicsandoutcomesofpatientswithacutemyeloidleukaemiatreatedwithvenetoclaxcombinationtherapyrealworldexperienceinbothfrontlineandrelapsedrefractorysettings AT sleong p547characteristicsandoutcomesofpatientswithacutemyeloidleukaemiatreatedwithvenetoclaxcombinationtherapyrealworldexperienceinbothfrontlineandrelapsedrefractorysettings AT zkirkham p547characteristicsandoutcomesofpatientswithacutemyeloidleukaemiatreatedwithvenetoclaxcombinationtherapyrealworldexperienceinbothfrontlineandrelapsedrefractorysettings AT awilson p547characteristicsandoutcomesofpatientswithacutemyeloidleukaemiatreatedwithvenetoclaxcombinationtherapyrealworldexperienceinbothfrontlineandrelapsedrefractorysettings AT rburt p547characteristicsandoutcomesofpatientswithacutemyeloidleukaemiatreatedwithvenetoclaxcombinationtherapyrealworldexperienceinbothfrontlineandrelapsedrefractorysettings AT rsellar p547characteristicsandoutcomesofpatientswithacutemyeloidleukaemiatreatedwithvenetoclaxcombinationtherapyrealworldexperienceinbothfrontlineandrelapsedrefractorysettings AT afielding p547characteristicsandoutcomesofpatientswithacutemyeloidleukaemiatreatedwithvenetoclaxcombinationtherapyrealworldexperienceinbothfrontlineandrelapsedrefractorysettings AT rgupta p547characteristicsandoutcomesofpatientswithacutemyeloidleukaemiatreatedwithvenetoclaxcombinationtherapyrealworldexperienceinbothfrontlineandrelapsedrefractorysettings AT epayne p547characteristicsandoutcomesofpatientswithacutemyeloidleukaemiatreatedwithvenetoclaxcombinationtherapyrealworldexperienceinbothfrontlineandrelapsedrefractorysettings AT mmansour p547characteristicsandoutcomesofpatientswithacutemyeloidleukaemiatreatedwithvenetoclaxcombinationtherapyrealworldexperienceinbothfrontlineandrelapsedrefractorysettings AT pkottaridis p547characteristicsandoutcomesofpatientswithacutemyeloidleukaemiatreatedwithvenetoclaxcombinationtherapyrealworldexperienceinbothfrontlineandrelapsedrefractorysettings AT akhwaja p547characteristicsandoutcomesofpatientswithacutemyeloidleukaemiatreatedwithvenetoclaxcombinationtherapyrealworldexperienceinbothfrontlineandrelapsedrefractorysettings AT jonions p547characteristicsandoutcomesofpatientswithacutemyeloidleukaemiatreatedwithvenetoclaxcombinationtherapyrealworldexperienceinbothfrontlineandrelapsedrefractorysettings |